RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer
Data from the Madeline study
Richardson, D., Zhan, L., Reynolds, M., Odom, D., Mcroy, L., Mitra, D., Zelnak, A., & Jones, C. (2019). Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: Data from the Madeline study. Value in Health, 22(S3), S527. https://doi.org/10.1016/j.jval.2019.09.657
